Mohr Capital Sells Wendy’s Restaurant Property In Scottsdale
A Dallas-based, privately held real estate investment firm, Mohr Capital, has sold a retail property in Scottsdale, AZ, one of the most affluent suburbs within the Phoenix area. The location’s tenant, Wendy’s, is a publicly traded restaurant operator with approximately 7,000 locations across the United States. The Scottsdale location is a corporate-guaranteed and large franchisee operated restaurant. “We are proud to … Continue reading Mohr Capital Sells Wendy’s Restaurant Property In Scottsdale Continue Reading


Hagens Berman also encourages potential whistleblowers to consult with its attorneys. Relevant Holding Period: Before Sept. 10, 2020Visit: www.hbsslaw.com/investor-fraud/NKLAContact An Attorney Now: NKLA@hbsslaw.com 844-916-0895 Nikola Corporation (NKLA) Investigation The investigation centers on whether Nikola and its founder misrepresented the capabilities of its electric truck and technologies. Prior to and since going public in early June 2020, Nikola has touted the production …
Amyris, Inc., a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, responds to LAVVAN, Inc.’s (LAVVAN) press release related to its commencement of a lawsuit against Amyris, Inc. (Amyris) for patent infringement and trade secret misappropriation on Thursday, September 10, 2020. …
SouthGobi Resources Ltd. announces that it was notified by the Toronto Stock Exchange (“TSX”) on September 11, 2020 that it is reviewing the eligibility for continued listing of the Company’s common shares on the TSX pursuant to the TSX’s Remedial Review Process (“TSX Delisting Review”). The Company has been granted 120 days from the date …
Elevation Financial Group, a provider of senior and multifamily affordable housing, announces the disposition of Elevation Real Property Fund V asset, Serenity Townhomes at Montgomery. The 192-unit multifamily community sold for $6.9 million and represents the disposition of the final asset in Fund V. (PRNewsfoto/Elevation Financial Group, LLC) (PRNewsfoto/Elevation Financial Group, LLC) Purchased in 2015 for $3.45 million, …
89bio, Inc. announced positive topline results from its Phase 1b/2a trial with BIO89-100, an investigational FGF21 analog, in patients with nonalcoholic steatohepatitis (NASH). All dose groups demonstrated significant reductions in liver fat at week 13, with relative reductions up to 60% versus baseline and up to 70% versus placebo, as measured by magnetic resonance imaging …